Report of the 4th meeting on the “Evaluation of pandemic influenza prototype vaccines in clinical trials”: World Health Organization, Geneva, Switzerland, 14–15 February 2008

This publication has 10 references indexed in Scilit:

• Flu Virus Research Yields Results but No Magic Bullet for Pandemic
  Science, 2008
• Update on Avian Influenza A (H5N1) Virus Infection in Humans
  New England Journal of Medicine, 2008
• Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial
  The Lancet, 2007
• Efficacy and Safety of a Live Attenuated, Cold-Adapted Influenza Vaccine, Trivalent Against Culture-Confirmed Influenza in Young Children in Asia
  The Pediatric Infectious Disease Journal, 2007
• Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children
  New England Journal of Medicine, 2007
• Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial
  The Lancet, 2006
• Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial
  The Lancet, 2006
• Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine
  New England Journal of Medicine, 2006
• Cross‐Reactivity to Highly Pathogenic Avian Influenza H5N1 Viruses after Vaccination with Nonadjuvanted and MF59‐Adjuvanted Influenza A/Duck/Singapore/97 (H5N3) Vaccine: A Potential Priming Strategy
  The Journal of Infectious Diseases, 2005
• Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza
  The Lancet, 2001